(Q39319692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Bioprocess development for canine adenovirus type 2 vectors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Ana S. Coroadinha

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Eric J Kremer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Paula Marques Alves

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

P Fernandes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

V M Santiago

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

5 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

353-360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2012.52

7 February 2020

exact match

0 references

cites work

From the first to the third generation adenoviral vector: what parameters are governing the production yield?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Characterization of cis-acting sequences involved in canine adenovirus packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

An update on canine adenovirus type 2 and its vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Serum free cell culture: the free access online database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Production of first generation adenoviral vectors for preclinical protocols: amplification, purification and functional titration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

HPLC purification of adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Concentration and purification of rubella virus using monolithic chromatographic support

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Reduced surface area chromatography for flow-through purification of viruses and virus like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Production of adenovirus vector for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Development and optimization of an adenovirus production process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Three-dimensional structure of canine adenovirus serotype 2 capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Overview of current scalable methods for purification of viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Adenovirus vector production and purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Good manufacturing practice production of adenoviral vectors for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Towards purification of adenoviral vectors based on membrane technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

293 cell cycle synchronisation adenovirus vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

A real-time PCR assay for quantification of canine adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

CAR-associated vesicular transport of an adenovirus in motor neuron axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

inferred from DOI database lookup

7 January 2021

based on heuristic

Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.52

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2012.52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763405%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference